Hillevax Stock Analysis

Hillevax Stock Analysis Notes

About 17.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.52. Some equities with similar Price to Book (P/B) outperform the market in the long run. Hillevax recorded a loss per share of 3.09. The entity had not issued any dividends in recent years. HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. Hillevax operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 15 people. To learn more about Hillevax call the company at 617 213 5054 or check out https://www.hillevax.com.

Hillevax Investment Alerts

Hillevax Upcoming and Recent Events

Hillevax Largest EPS Surprises

View All Earnings Estimates

Hillevax Stock Institutional Investors

Note, although Hillevax's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Hillevax Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 96.62 M.

Hillevax Profitablity

Management Efficiency

Hillevax has return on total asset (ROA) of (0.289) % which means that it has lost $0.289 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6224) %, meaning that it created substantial loss on money invested by shareholders. Hillevax's management efficiency ratios could be used to measure how well Hillevax manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.38 in 2024. Return On Capital Employed is likely to rise to -0.4 in 2024. At this time, Hillevax's Net Tangible Assets are fairly stable compared to the past year. Other Assets is likely to rise to about 2 M in 2024, whereas Total Assets are likely to drop slightly above 173.7 M in 2024.

Technical Drivers

As of the 26th of November, Hillevax retains the Market Risk Adjusted Performance of 0.0218, risk adjusted performance of 0.0143, and Downside Deviation of 2.16. Hillevax technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Hillevax Price Movement Analysis

Hillevax Insider Trading Activities

Hillevax Outstanding Bonds

Hillevax Predictive Daily Indicators

Hillevax Forecast Models

Hillevax's time-series forecasting models are one of many Hillevax's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Hillevax's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Hillevax prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Hillevax shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Hillevax. By using and applying Hillevax Stock analysis, traders can create a robust methodology for identifying Hillevax entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Hillevax analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Hillevax analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Hillevax stock analysis indicators help investors evaluate how Hillevax stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Hillevax shares will generate the highest return on investment. By understating and applying Hillevax stock analysis, traders can identify Hillevax position entry and exit signals to maximize returns.

When running Hillevax's price analysis, check to measure Hillevax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hillevax is operating at the current time. Most of Hillevax's value examination focuses on studying past and present price action to predict the probability of Hillevax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hillevax's price. Additionally, you may evaluate how the addition of Hillevax to your portfolios can decrease your overall portfolio volatility.